Richard I Steinhart insider trades: BioXcel Therapeutics (BTAI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | BTAI | ↓ Sell | 6,845 | $1.08 | $7K | Direct | May 22, 2026 (2d) |
| Dec 16, 2024 | BTAI | ↓ Sell | 577 | $0.36 | $207 | Direct | Dec 17, 2024 (1d) |
| Oct 3, 2024 | BTAI | ↓ Sell | 7,175 | $0.55 | $4K | Direct | Oct 3, 2024 (0d) |
| Sep 16, 2024 | BTAI | ↓ Sell | 356 | $0.69 | $246 | Direct | Sep 17, 2024 (1d) |
| Jun 17, 2024 | BTAI | ↓ Sell | 372 | $1.26 | $470 | Direct | Jun 18, 2024 (1d) |
| Apr 4, 2024 | BTAI | ↓ Sell | 1,069 | $2.63 | $3K | Direct | Apr 8, 2024 (4d) |
| May 15, 2023 | BTAI | ↓ Sell | 5,000 | $27.17 | $136K | Direct | May 16, 2023 (1d) |
| Mar 15, 2023 | BTAI | ↓ Sell | 2,084 | $19.50 | $41K | Direct | Mar 16, 2023 (1d) |
| Feb 1, 2021 | BTAI | ↓ Sell | 3,750 | $48.15 | $181K | Direct | Feb 3, 2021 (2d) |
| Dec 3, 2018 | BTAI | ↑ Buy | 500 | $5.20 | $3K | Direct | Dec 4, 2018 (1d) |
| Nov 30, 2018 | BTAI | ↑ Buy | 500 | $5.00 | $3K | Direct | Nov 30, 2018 (0d) |
| Nov 29, 2018 | BTAI | ↑ Buy | 500 | $5.00 | $3K | Direct | Nov 30, 2018 (1d) |
| Apr 14, 2016 | ATNM | ↑ Buy | 2,500 | $2.01 | $5K | Direct | Apr 18, 2016 (4d) |
| Jun 25, 2013 | MELA | ↑ Buy | 3,000 | $0.81 | $2K | Direct | Jun 25, 2013 (0d) |
| Aug 12, 2010 | MELA | ↑ Buy | 1,000 | $6.32 | $6K | Direct | Aug 12, 2010 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BTAI insiders
Open-market trades in the last 12 months
About Richard I Steinhart's insider trades
Richard I Steinhart is Chief Financial Officer at BioXcel Therapeutics (BTAI). Since Aug 12, 2010, Richard has reported 6 open-market purchases worth $21K and 9 sales worth $372K on SEC Form 4. In the last 12 months: 1 sale ($7K).
Their filings also include grants and awards (44 filings), option exercises (19 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.